APA (7th ed.) Citation

JE, C. P., A, G. L., PR, C. P., IG, L. R., CG, M. M., YV, J. A., . . . Ó, G. L. (2026). Optimizing Blinatumomab Access for Low- and Middle-Income Countries: Feasibility of a Shortened, Vial-Sharing, Outpatient Approach for Pediatric ALL. JCO global oncology, 12, e2500469. https://doi.org/10.1200/GO-25-00469

Chicago Style (17th ed.) Citation

JE, Colunga Pedraza, Gómez-De León A, Colunga Pedraza PR, López Reyna IG, Martínez Martínez CG, Jiménez Antolinez YV, Jaime-Pérez JC, Gómez Almaguer D, and González Llano Ó. "Optimizing Blinatumomab Access for Low- and Middle-Income Countries: Feasibility of a Shortened, Vial-Sharing, Outpatient Approach for Pediatric ALL." JCO Global Oncology 12 (2026): e2500469. https://doi.org/10.1200/GO-25-00469.

MLA (9th ed.) Citation

JE, Colunga Pedraza, et al. "Optimizing Blinatumomab Access for Low- and Middle-Income Countries: Feasibility of a Shortened, Vial-Sharing, Outpatient Approach for Pediatric ALL." JCO Global Oncology, vol. 12, 2026, p. e2500469, https://doi.org/10.1200/GO-25-00469.